|Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?|
M Kerschensteiner, E Gallmeier, L Behrens, VV Leal, T Misgeld, ...
The Journal of experimental medicine 189 (5), 865-870, 1999
|In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor|
MS Van Der Heijden, JR Brody, DA Dezentje, E Gallmeier, ...
Clinical Cancer Research 11 (20), 7508-7515, 2005
|Functional defects in the fanconi anemia pathway in pancreatic cancer cells|
MS Van der Heijden, JR Brody, E Gallmeier, SC Cunningham, ...
The American journal of pathology 165 (2), 651-657, 2004
|Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer|
JM Winter, AH Ting, F Vilardell, E Gallmeier, SB Baylin, RH Hruban, ...
Clinical cancer research 14 (2), 412-418, 2008
|Targeted Disruption of FANCC and FANCG in Human Cancer Provides a Preclinical Model for Specific Therapeutic Options|
E Gallmeier, ES Calhoun, C Rago, JR Brody, SC Cunningham, T Hucl, ...
Gastroenterology 130 (7), 2145-2154, 2006
|Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays|
ES Calhoun, T Hucl, E Gallmeier, KM West, DE Arking, A Maitra, ...
Cancer research 66 (16), 7920-7928, 2006
|Knock-in of Mutant K-ras in Nontumorigenic Human Epithelial Cells as a New Model for Studying K-ras–Mediated Transformation|
H Konishi, B Karakas, AM Abukhdeir, J Lauring, JP Gustin, JP Garay, ...
Cancer research 67 (18), 8460-8467, 2007
|Ultra-fast high-resolution agarose electrophoresis of DNA and RNA using low-molarity conductive media|
JR Brody, ES Calhoun, E Gallmeier, TD Creavalle, SE Kern
Biotechniques 37 (4), 598-602, 2004
|Inhibition of Ataxia Telangiectasia‐and Rad3‐related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133+ …|
E Gallmeier, PC Hermann, MT Mueller, JG Machado, A Ziesch, ...
Stem Cells 29 (3), 418-429, 2011
|A syngeneic variance library for functional annotation of human variation: application to BRCA2|
T Hucl, C Rago, E Gallmeier, JR Brody, M Gorospe, SE Kern
Cancer research 68 (13), 5023-5030, 2008
|Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor …|
SC Cunningham, E Gallmeier, T Hucl, DA Dezentje, ES Calhoun, G Falco, ...
Cancer research 66 (11), 5560-5564, 2006
|Absence of Specific Cell Killing of the BRCA2-Deficient Human Cancer Cell Line CAPAN1 by Poly (ADP-Ribose) Polymerase Inhibition|
E Gallmeier, SE Kern
Cancer biology & therapy 4 (7), 703-706, 2005
|JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand|
SR Mucha, A Rizzani, AL Gerbes, P Camaj, WE Thasler, CJ Bruns, ...
Gut 58 (5), 688-698, 2009
|High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor–dependent MCAT motif|
T Hucl, JR Brody, E Gallmeier, CA Iacobuzio-Donahue, IK Farrance, ...
Cancer research 67 (19), 9055-9065, 2007
|Expression, cellular distribution, and prognostic relevance of TRAIL receptors in hepatocellular carcinoma|
L Kriegl, A Jung, J Engel, R Jackstadt, AL Gerbes, E Gallmeier, JA Reiche, ...
Clinical Cancer Research 16 (22), 5529-5538, 2010
|Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer|
E Punkenburg, T Vogler, M Büttner, K Amann, M Waldner, R Atreya, ...
Gut 65 (7), 1139-1150, 2016
|Targeting Fanconi anemia/BRCA2 pathway defects in cancer: the significance of preclinical pharmacogenomic models|
E Gallmeier, SE Kern
Clinical cancer research 13 (1), 4-10, 2007
|JAK and STAT proteins are expressed and activated by IFN‐γ in rat pancreatic acinar cells|
E Gallmeier, C Schäfer, P Moubarak, A Tietz, I Plössl, R Huss, B Göke, ...
Journal of cellular physiology 203 (1), 209-216, 2005
|Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy|
JR Brody, T Hucl, E Gallmeier, JM Winter, SE Kern, KM Murphy
Cancer research 66 (19), 9369-9373, 2006
|Overexpression of heat shock protein 27 (HSP 27) increases gemcitabine sensitivity in pancreatic cancer cells through S‐phase arrest and apoptosis|
Y Guo, A Ziesch, S Hocke, E Kampmann, S Ochs, EN De Toni, B Göke, ...
Journal of cellular and molecular medicine 19 (2), 340-350, 2015